2025 Regular Session • Kentucky Legislature
SB14: AN ACT relating to pharmaceutical manufacturers.
Legislative Summary
Create a new section of KRS Chapter 315 to define terms, prohibit discrimination against 340B covered entities by pharmaceutical manufacturers, and authorize the Attorney General to investigation violations.
Demographic Impact
Overall analysis of equity impact
70% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/7/2025
introduced in Senate
Senate
1/7/2025
to Committee on Committees (S)
Senate
1/9/2025
to Health Services (S)
Senate
2/5/2025
reported favorably, 1st reading, to Calendar
Senate
2/6/2025
2nd reading, to Rules
Senate
2/7/2025
floor amendments (1-title) and (2) filed
Senate
2/12/2025
posted for passage in the Regular Orders of the Day for Thursday, February 13, 2025
Senate
2/13/2025
3rd reading
Senate
2/13/2025
floor amendments (2) and (1-title) withdrawn
Senate
2/13/2025
passed 33-4
Senate
2/14/2025
received in House
House of Representatives
2/14/2025
to Committee on Committees (H)
House of Representatives
Amendments
Senate Floor Amendment
Senate Floor Amendment 1
Not Adopted
Senate Floor Amendment
Senate Floor Amendment 2
Not Adopted
Roll Call Votes
Senate: Third Reading RSN# 3357
2/13/2025
33
Yea
4
Nay
0
Not Voting
1
Absent
Result: PASSED
Status Information
Current Status
Engrossed(2/14/2025)
Chamber
House of Representatives
Committee
Committee On Committees(House of Representatives)
Sponsors
Republican: 4
Primary Sponsor
Stephen Meredith
Republican